For additional information:Download the MARIPOSA 2 Study brochure
Participants in the MARIPOSA 2 Study will be randomly assigned to 1 of 3 study treatment groups. Each group will receive a different combination of investigational medications while completing various study tests and procedures.
All study-required visits, tests, and medications will be provided at no cost to qualified participants. The study will not pay for other medical care or current medication(s) needed to support your daily healthcare routine. In addition, reimbursement for study-required travel, meals, and parking may be available.
This initial appointment is an opportunity for you to:
Participants in the study will be randomly assigned to 1 of 3 study treatment groups: study treatment Arm A, B, or C. Each group will receive a different combination of investigational medications.
You should make sure to inform your doctor of any new symptoms you experience while participating in the study. If you experience worsening of your disease at any time during the study, your study doctor will ask you to come to the study clinic to determine disease progression. If your disease is progressing, you will be asked to complete an end of treatment visit 30 days after your last dose of investigational medications. You will then enter the follow-up period with visits to the study clinic or telephone contact every 12 weeks until the end of study to find out how you are doing, if you have had any side effects, and if you have started any new cancer treatments.
The more we learn, the farther we can go.